NL-OMON22679招募中不适用
Three-armed Randomized Controlled Trial on the efficacy of traumafocused interventions in refugee children
Vereniging EMDR Nederland (VEN); EMDR Europe; ZONMW; Stichting tot steun VCVGZ0 个研究点目标入组 93 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 93
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Eligible participants for this study must meet all of the following criteria:(1) children and adolescents of ages 8 and 18 years; (2) partial or full PTSD as reported by the child (interviewed with the Clinician-Administered PTSD Scale for DSM 5 - Child/Adolescent Version (CAPS-CA-5; Pynoos et al., 2015)). Partial PTSD is defined as either fulfilling three of the four symptom clusters or one symptom present in each of the four symptom clusters. Participants will be included when they (3) are accompanied by at least one caregiver; (4) applied for asylum in the Netherlands or are residing in the Netherlands since January 2015 or later; (5) elementary reading and writing level.
排除标准
- •A potential participant who meets any of the following criteria will be excluded from participation in this study: (1) intelligence level (<80); (2) acute interfering psychiatric disorder that needs to be treated first; (4) brain damage; (5) acute threat of deportation or moving within intervention period; (6) anti-epileptic and neuro epileptic medication; or (7) current severe substance abuse.
研究者
相似试验
尚未招募
3 期
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal MelanomaEye cancer1004706010030054NL-OMON56767Aura Biosciences, Inc3
进行中（未招募）
1 期
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011)Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal MelanomaPrimary Indeterminate Lesions or Small Choroidal MelanomaMedDRA version: 20.0Level: HLTClassification code: 10030052Term: Ocular melanomas Class: 10029104MedDRA version: 21.0Level: PTClassification code: 10025839Term: Malignant neoplasm of choroid Class: 100000004864MedDRA version: 21.1Level: PTClassification code: 10008773Term: Choroid melanoma Class: 100000004864MedDRA version: 21.1Level: PTClassification code: 10081431Term: Uveal melanoma Class: 100000004864CTIS2023-504655-27-00Aura Biosciences Inc.267
尚未招募
3 期
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal MelanomaNL-OMON56772Aura Biosciences, Inc.3
已完成
不适用
Study on efficacy of joint lavage (arthrocentesis) with and without applied pressure for treatment of temporomandibular joint disorder (internal derangement)CTRI/2015/03/005621Dr Akilesh R40
撤回
不适用
Better Drive 2: Effect of computerised cognitive training and on-road skills training on driving safety in older adultsAgeing associated driving impairmentInjuries and Accidents - Other injuries and accidentsPhysical Medicine / Rehabilitation - Occupational therapyNeurological - DementiasACTRN12618000405213The Australian National University126